Ⅰ. Introduction
Extensive research on TCs and TC analogues has shown that this antibiotic family has non-antimicrobial properties that can modulate host-response by various mechanisms 6, [11] [12] [13] . Current evidence suggests that TCs are able to inhibit collagenolytic activity through the inhibition of MMPs 5, [14] [15] [16] .
Suppression of MMP-mediated events with
TCs results in decreased connective tissue breakdown and bone resorption 15, 17 . It was shown that TCs sustained their MMP inhibitory effect even at doses below those needed for antimicrobial efficacy 15 . In this regard, a specially formulated subantimicrobial dose doxycycline (SDD) was approved by Food and Drug Administration as an adjunct to non-surgical periodontal therapy 18 .
The importance of the host inflammatory response in periodontal pathogenesis presents the opportunity for exploiting new treatment strategies for periodontitis by means of host response modulation. Host modulatory therapy (HMT) can be combined with traditional periodontal therapies that reduce the bacterial burden (e.g. SRP) and also risk factor modification (e.g. smoking cessation therapy) to constitute a compre- 
Ⅲ. Results
The public's knowledge and opinions on periodontal drugs Table 6 . Individuals' sources of information on drugs for periodontal diseases (Table 4) .
On drug selection most people were influenced by pharmacist (64.3%) and family members/acquaintances (28.6%) ( Table 5 ).
Majority of the people acquired the knowledge of drugs for periodontal diseases through advertisement (61%) from television (52%) and newspaper (9%). Only 12% of the people reported that they had got knowledge of drugs for periodontal diseases from dental clinic (Table 6 ).
On the effect of periodontal drugs, 35% of the people thought 'somewhat therapeutic' and 20% thought 'preventive but not therapeutic'. However, 41% of the people didn't reply to this question ( Table 7) .
63% of the people had intention of drug medication for their periodontal health (Table 2 ). And about half (59%) of the people reported they would ask to medical doctors or dentists for choice of drugs. 20%
would ask to pharmacist and 14% would choice drugs by themselves (Table 8 ). Zea mays extract drugs) were administered to National Health Institute Corporation (Table 9) .
From the Pubmed homepage, 47 articles related with ascorbic acid and lysozyme containing drugs, 6 for Zea mays extract drugs, 26 for SDDs, and 2 for avocado-soya unsaponifiables were searched (Table 10 ).
Ⅳ. Discussion
The investigation of this study was performed to clarify the public's level of recognition about drugs for periodontal diseases. on role of dentists is large.
From the overall results of the survey, And it also promotes synthesis of TGF-β, which plays a role in activation, proliferation and cartilage matrix synthesis of chondrocytes 34, 35 . Although Avocado-soya unsaponifiables has been developed primarily for the treatment of osteoarthritis, it can be used in dental field because IL-1 and TGF-β also plays an important role in pathogenesis and progression of periodontal disease.
However, there is no study about the feasibility of using this medicine to periodontal patients. So studies on this drug should be performed in the future.
Ⅴ. Conclusions
This study aimed to determine the pub- Ⅵ. References 
